日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Route-dependent dissemination with conserved blood-tumor barrier ultrastructure in intracranial metastasis models

颅内转移模型中，肿瘤扩散途径依赖性与血肿瘤屏障超微结构的保留相关

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-37760-z
Zhao, Jian; Zhang, Yuehua; Wei, Zhigong; Li, Kai; Li, Dan; Wang, Yongsheng
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Surgical Margin Reduction After Immunotargeted Neoadjuvant Therapy in Locally Advanced Hypopharyngeal Carcinoma: A Preliminary Margin Results from neoCHANCE-1 Trial

局部晚期下咽癌免疫靶向新辅助治疗后手术切缘缩小：neoCHANCE-1试验的初步切缘结果

期刊:Journal of Otolaryngology-Head & Neck Surgery
影响因子:2.2
doi:10.1177/19160216251415526
Wang, Dejuan; Wei, Jixing; Jiang, Zheng; Wei, Zhigong; Ainiwaer, Mailudan; Zhao, Pengwei; Fan, Lixiao; Wang, Longhao; Li, Leyu; Lei, Dapeng; Chen, Fei; Chen, Huijiao; Peng, Xingchen; Liu, Jun
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Bioinspired ruthenium-manganese-oxygen complex for biocatalytic and radiosensitization therapies to eradicate primary and metastatic tumors.

仿生钌-锰-氧复合物用于生物催化和放射增敏疗法，以根除原发性和转移性肿瘤

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-62999-x
Li Ruidan, Wang Ting, Mu Shengdong, Xing Zhenyu, Ding Zhiying, Wen Qinlong, Wei Zhigong, Wang Xiaolin, Adeli Mohsen, Li Shuang, Cheng Chong, Peng Xingchen
肿瘤
发表日期：2025
文献求助 收藏

The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular Carcinoma

PI3K/Akt/mTOR通路：IR/MASH相关肝细胞癌中的免疫代谢调控

期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.120657
Zhao, Jian; Zhang, Yuehua; Wei, Zhigong; Li, Kai; Sun, Lei; Li, Dan; Wang, Yongsheng
肿瘤
mTOR
肿瘤免疫
信号转导
PI3K/Akt
代谢
细胞生物学
免疫代谢
免疫/内分泌
发表日期：2025
文献求助 收藏

Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy: A Randomized Clinical Trial

为接受放射治疗的头颈癌患者提供多学科团队支持：一项随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.47590
Pei, Yiyan; Wang, Jingjing; Li, Juejin; Chen, Ye; He, Jinlan; Wei, Zhigong; Liu, Zheran; Su, Yonglin; Dai, Tingting; Yin, Li; Deng, Yaotiao; Zhou, Jitao; Tian, Hangrui; Li, Yunhuan; Chen, Xiaoli; Zhang, Shu; Chen, Yang; Yan, Qianwen; Li, Ruidan; Jiang, Zheng; Hu, Xiaolin; Peng, Xingchen
肿瘤
肿瘤免疫
头颈癌
发表日期：2025
文献求助 收藏

Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors

淋巴细胞亚群百分比与接受PD-L1抑制剂治疗的复发或转移性鼻咽癌患者预后的相关性

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03885-1
Diao, Jianming; Wei, Zhigong; Pei, Yiyan; Ge, Junyou; Qing, Yan; Wei, Youneng; Chen, Ye; Peng, Xingchen
细胞生物学
鼻咽癌
PD-L1
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)

基线转移部位作为 PD-L1 抑制剂治疗复发或转移性鼻咽癌的预测因子：多中心、单臂、II 期研究 (KL-A167) 的二次分析

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03905-0
Li, Yuantai; Min, Yu; Wei, Zhigong; Liu, Zheran; Pei, Yiyan; Yang, Yujie; Gao, Kun; Song, Ge; Xu, Shihong; He, Shuangshuang; Ge, Junyou; Qing, Yan; Wei, Youneng; Ai, Ping; Chen, Ye; Peng, Xingchen
鼻咽癌
肿瘤
肿瘤免疫
PD-L1
发表日期：2025
文献求助 收藏

Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)

更正：基线转移部位作为 PD-L1 抑制剂治疗复发或转移性鼻咽癌的预测因子：多中心、单臂、II 期研究 (KL-A167) 的二次分析

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04162-5
Li, Yuantai; Min, Yu; Wei, Zhigong; Liu, Zheran; Pei, Yiyan; Yang, Yujie; Gao, Kun; Song, Ge; Xu, Shihong; He, Shuangshuang; Ge, Junyou; Qing, Yan; Wei, Youneng; Ai, Ping; Chen, Ye; Peng, Xingchen
鼻咽癌
肿瘤
肿瘤免疫
PD-L1
发表日期：2025
文献求助 收藏

Correction: Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors

更正：淋巴细胞亚群百分比与接受PD-L1抑制剂治疗的复发或转移性鼻咽癌患者预后的相关性

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04117-w
Diao, Jianming; Wei, Zhigong; Pei, Yiyan; Ge, Junyou; Qing, Yan; Wei, Youneng; Chen, Ye; Peng, Xingchen
肿瘤
肿瘤免疫
PD-L1
鼻咽癌
细胞生物学
发表日期：2025
文献求助 收藏

Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2

患者体内自然感染 Omicron BA.5.2 可产生针对 SARS-CoV-2 的广泛免疫反应

期刊:Microorganisms
影响因子:4.2
doi:10.3390/microorganisms13040746
Li, Le; Feng, Tang; Shen, Quan; Shi, Xiaoshan; Wei, Zhigong; Chen, Wanze; Yang, Fan; Zhu, Yueting; Zhang, Chengxin; Zhang, Shuang; Zhang, Qisi; Fu, Shengwei; Wang, Ning; Tian, Wen-Xia; Liu, Jiyan; Si, Longlong
炎症/感染
SARS-CoV-2
免疫/内分泌
发表日期：2025
文献求助 收藏